AARD vs CRM · $284.4M cap vs P/E 41, rev $11.35B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Salesforce.com Inc (CRM) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Salesforce.com Inc (CRM) is a software - application company listed on US. It is led by Marc Benioff.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported CRM revenue for 2026-07-31 was $11.35B. Net income was $3.53B. Revenue was up 1.9% from 2026-04-30 to 2026-07-31. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
AARD currently screens at market cap $284.4M. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
Not investment advice. Open the AARD and CRM stock pages for the full models.
Not investment advice.